Spinal Cord Injuries
Recent clinical, regulatory, research and industry developments relating to this disease.
Effects of the Serotonin Precursor, 5-hydroxytryptophan, in the Injured Human Spinal Cord
Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI
Advances in Neuromodulation and Digital Brain-Spinal Cord Interfaces for Spinal Cord Injury.
Regeneration and Plasticity Induced by Epidural Stimulation in a Rodent Model of Spinal Cord Injury.
Brain Plasticity in Patients with Spinal Cord Injuries: A Systematic Review.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 3 clinical trials expected to report results, the earliest in Q4 2026.
- Active recent publication activity.
- 1 industry development reported.
- Q4 2026Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
- Q3 2028Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes
- Q4 2028Safety of Cultured Allogeneic Adult Umbilical-cord or Placental Derived Mesenchymal Stem Cell Intrathecal Injection for the Treatment of Spinal Cord Injury
Research HighlightsViewHide
Clinical MilestonesViewHide
- 2026-10-20Safety of Cultured Allogeneic Adult Umbilical-cord or Placental Derived Mesenchymal Stem Cell Intrathecal Injection for the Treatment of Spinal Cord InjuryResults expected Q4 2028
- 2026-04-13Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 DiabetesResults expected Q3 2028
- 2025-12-16Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord InjuriesResults expected Q4 2026
- 2026-08-31Feasibility of Early Gabapentin as an Intervention for NeurorecoveryPrimary completion
- 2026-05-13Effects of the Serotonin Precursor, 5-hydroxytryptophan, in the Injured Human Spinal CordPrimary completion
- 2026-04-15Hybrid Functional Electrical Stimulation Exercise to Prevent Cardiopulmonary Declines in High-level Spinal Cord InjuryPrimary completion
Industry & MarketViewHide
- 2026-08-19Wandercraft Receives FDA Clearance for Eve, the World’s First Self-Balancing Personal Exoskeleton, for Eligible Wheelchair Users Living with Spinal Cord Injuries at Any LevelRegulatory news · Orthopedics This Week
- 2026-10-20ClinicalSafety of Cultured Allogeneic Adult Umbilical-cord or Placental Derived Mesenchymal Stem Cell Intrathecal Injection for the Treatment of Spinal Cord InjuryResults expected Q4 2028
- 2026-08-31ClinicalFeasibility of Early Gabapentin as an Intervention for NeurorecoveryPrimary completion
- 2026-08-19IndustryWandercraft Receives FDA Clearance for Eve, the World’s First Self-Balancing Personal Exoskeleton, for Eligible Wheelchair Users Living with Spinal Cord Injuries at Any LevelRegulatory news · Orthopedics This Week
- 2026-05-13ClinicalEffects of the Serotonin Precursor, 5-hydroxytryptophan, in the Injured Human Spinal CordPrimary completion
- 2026-04-15ClinicalHybrid Functional Electrical Stimulation Exercise to Prevent Cardiopulmonary Declines in High-level Spinal Cord InjuryPrimary completion
- 2026-04-13ClinicalGlycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 DiabetesResults expected Q3 2028
- 2026-03-18ClinicalBrivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialResults posted
- 2026-02-28ResearchReal-time brain-computer interface control of walking exoskeleton with bilateral sensory feedback.Lim J · 2026
- 2026-01-21ResearchMagnetically Responsive Piezoelectric Nanocapacitors Enhance Neural Recovery Following Spinal Cord Injury via Targeted Spinal Magnetic Stimulation.Xiao Z · 2026
- 2025-12-16ClinicalSildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord InjuriesResults expected Q4 2026
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Spinal Cord Injuries23
- Brain-Computer Interfaces5
- Nerve Regeneration3
- Neuroinflammatory Diseases3
- Neuronal Plasticity3
- Aging2
- Axons2
- Brain2
Leading journals6
- International journal of molecular sciences5
- The Journal of neuroscience : the official journal of the Society for Neuroscience3
- Brain, behavior, and immunity2
- Journal of neuroinflammation2
- Nature communications2
- Signal transduction and targeted therapy2
Leading researchers8
- Wu J4
- Faden AI3
- Lei Z3
- Li Y3
- Xu W3
- Cheng L2
- Courtine G2
- Gong Z2
Affiliations (unnormalised)6
- Department of Anesthesiology and Center for Shock3
- Center for Neuroprosthetics and Brain Mind Institute2
- Co-innovation Center of Neuroregeneration2
- Huashan Hospital2
- Key Laboratory of Spine and Spinal cord Injury Repair and Regeneration (Tongji University)2
- Tongji Hospital2
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Spinal cord injuries are traumatic injuries to the spinal cord caused by penetrating or non-penetrating external forces, including wounds and gunshot or whiplash-type trauma. They can produce major motor, sensory, and autonomic dysfunction and may be anatomically complete or incomplete. The literature also treats them as a condition with important acute and chronic phases, including complications and rehabilitation needs.
The cause is traumatic external force to the spinal cord, including penetrating and non-penetrating injury. The grounding specifically includes wounds, gunshot injury, and whiplash injuries as examples. No non-traumatic causes are supported here.
The initial mechanical insult disrupts axons, blood vessels, and cell membranes, producing vascular disruption, blood-spinal cord barrier rupture, hemorrhage, and ischemia. A secondary injury cascade then develops with edema, inflammation, oxidative stress, excitotoxicity, electrolyte shifts, free radical production, and delayed apoptotic cell death. Over time, glial and fibrotic scarring and inhibitory molecules in myelin and extracellular matrix limit axonal regeneration and functional recovery.
The grounding does not support general pre-injury risk factors beyond exposure to traumatic external forces. It does indicate that penetrating trauma, gunshot injury, and whiplash-type injury are relevant injury mechanisms. No additional demographic or clinical risk factors are supported.
The supplied grounding supports treatment at the level of surgery, rehabilitation, and emerging neuroprotective or neuro-regenerative therapies. Reviews also describe regenerative approaches aimed at blocking inhibitory signals and promoting axonal regrowth, neuronal recovery, and functional restoration. However, no approved therapy to restore mobility and sensation is identified in the grounding, so standard care cannot be specified beyond these modality classes.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.